CN101816640B - 普拉格雷脂质体固体制剂 - Google Patents
普拉格雷脂质体固体制剂 Download PDFInfo
- Publication number
- CN101816640B CN101816640B CN2010101483769A CN201010148376A CN101816640B CN 101816640 B CN101816640 B CN 101816640B CN 2010101483769 A CN2010101483769 A CN 2010101483769A CN 201010148376 A CN201010148376 A CN 201010148376A CN 101816640 B CN101816640 B CN 101816640B
- Authority
- CN
- China
- Prior art keywords
- prasugrel
- liposome
- preparation
- tablet
- cholesterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101483769A CN101816640B (zh) | 2010-04-16 | 2010-04-16 | 普拉格雷脂质体固体制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101483769A CN101816640B (zh) | 2010-04-16 | 2010-04-16 | 普拉格雷脂质体固体制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101816640A CN101816640A (zh) | 2010-09-01 |
CN101816640B true CN101816640B (zh) | 2012-01-11 |
Family
ID=42652020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101483769A Expired - Fee Related CN101816640B (zh) | 2010-04-16 | 2010-04-16 | 普拉格雷脂质体固体制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101816640B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101947210B (zh) * | 2010-09-08 | 2012-08-01 | 海南美兰史克制药有限公司 | 苯磺酸左旋氨氯地平脂质体片剂 |
CN102078299B (zh) * | 2011-01-04 | 2012-09-26 | 海南美大制药有限公司 | 胞磷胆碱钠脂质体固体制剂 |
CN102764233A (zh) * | 2011-05-06 | 2012-11-07 | 四川大学 | 3-氨基-6-芳基-噻吩并[2,3-b]吡啶-2-甲酰胺类衍生物脂质体注射剂及制备工艺 |
CN103536535B (zh) * | 2013-10-31 | 2015-04-08 | 江苏阿尔法药业有限公司 | 一种达比加群酯脂质体 |
CN103622911B (zh) * | 2013-11-19 | 2015-12-30 | 常州金远药业制造有限公司 | 一种难溶性药物脂质体制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0720248A2 (pt) * | 2006-12-07 | 2013-12-31 | Lilly Co Eli | Artigo de fabricação de prasugrel |
CN101623259B (zh) * | 2009-07-23 | 2011-05-04 | 海南美大制药有限公司 | 阿莫西林脂质体固体制剂 |
CN101623258B (zh) * | 2009-07-23 | 2011-02-02 | 海南美大制药有限公司 | 盐酸雷尼替丁脂质体胶囊剂及其新应用 |
-
2010
- 2010-04-16 CN CN2010101483769A patent/CN101816640B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101816640A (zh) | 2010-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6588915B2 (ja) | Azd9291を含む医薬組成物 | |
US20180092875A1 (en) | Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose | |
KR20070095456A (ko) | 레베티라세탐의 서방형 제제 | |
CN101797230B (zh) | 一种氯沙坦钾氢氯噻嗪药物组合物脂质体固体制剂 | |
WO2006070781A1 (ja) | 塩基性薬物又はその塩を含有するマトリックス型徐放性製剤およびその製造方法 | |
CN101816640B (zh) | 普拉格雷脂质体固体制剂 | |
CN105998026A (zh) | 一种替卡格雷药物组合物及其制备方法 | |
CN101804029A (zh) | 阿托伐他汀脂质体、其制备方法及含有它的药物组合物 | |
CN102166208B (zh) | 赖诺普利氢氯噻嗪药物组合物脂质体固体制剂 | |
CN101972263B (zh) | 一种缬沙坦氢氯噻嗪药物组合物脂质体固体制剂 | |
CN102188417A (zh) | 决奈达隆药物组合物 | |
CN101862336B (zh) | 一种厄贝沙坦氢氯噻嗪药物组合物脂质体固体制剂 | |
CN102614182A (zh) | 一种复方氨酚肾素药物组合物脂质体固体制剂 | |
CN102727496A (zh) | 一种复方抗结核药口服固体制剂及其制备方法 | |
CN101829071B (zh) | 一种阿利克仑脂质体片剂 | |
CN101862329B (zh) | 一种氨氯地平阿托伐他汀钙药物组合物脂质体固体制剂 | |
CN102697765B (zh) | 盐酸雷尼替丁枸橼酸铋钾药物组合物固体脂质纳米粒制剂 | |
CN102133189B (zh) | 替米沙坦脂质体固体制剂 | |
CN101637451B (zh) | 一种氯诺昔康脂质体药物组合物及其固体制剂 | |
CN101912372A (zh) | 一种尼伐地平脂质体片剂 | |
CN102579344B (zh) | 氯沙坦钾脂质体固体制剂 | |
CN102068410B (zh) | 阿德福韦酯脂质体固体制剂 | |
CN102302452B (zh) | 匹伐他汀钙脂质体固体制剂 | |
CN102091044B (zh) | 一种头孢呋辛酯脂微球固体制剂 | |
CN102626395B (zh) | 一种阿利克仑缬沙坦药物组合物脂质体固体制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN LINGKANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HAINAN MEIDA PHARMACEUTICAL CO., LTD. Effective date: 20130723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570125 HAIKOU, HAINAN PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130723 Address after: 570216 Hainan Province, Haikou city Jinpan Industrial Development Zone Industrial Village No. 3-6 building Patentee after: Hainan Lingkang Pharmaceutical Co., Ltd. Address before: 570125 No. C03, Haikou Free Trade Zone, Hainan Patentee before: Hainan Meida Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120111 Termination date: 20160416 |
|
CF01 | Termination of patent right due to non-payment of annual fee |